NEETPGAI
FeaturesBlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Features
  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Contact & support

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Medicine/Spirometry — Interstitial Lung Disease with Reduced DLCO
    Spirometry — Interstitial Lung Disease with Reduced DLCO
    medium
    stethoscope Medicine

    A 68-year-old retired construction worker presents with 18 months of progressive dyspnea on exertion and non-productive cough. Examination reveals fine bibasilar velcro crackles and clubbing. HRCT shows subpleural, basal-predominant reticulation with honeycombing and traction bronchiectasis consistent with a definite UIP pattern. Spirometry demonstrates the pattern marked **A** in the diagram, with FVC 58% predicted, FEV1 62% predicted, FEV1/FVC 0.84, TLC 64% predicted, and DLCO 42% predicted. A 6-minute walk test shows exercise-induced desaturation from 96% to 84%. Which of the following best explains why the DLCO is reduced out of proportion to the reduction in lung volumes in the pattern marked **A**?

    A. Airway obstruction reducing ventilation to distal alveoli
    B. Increased total lung capacity due to air trapping in emphysematous spaces
    C. Preserved airway caliber with normal gas diffusion capacity
    D. Destruction of the alveolar-capillary membrane and obliteration of the pulmonary capillary bed

    Explanation

    Why "Destruction of the alveolar-capillary membrane and obliteration of the pulmonary capillary bed" is right

    In the restrictive pattern marked A (characteristic of idiopathic pulmonary fibrosis), the FEV1/FVC ratio is preserved or elevated (0.84 in this case) because both the numerator and denominator fall proportionally—airway caliber is preserved. However, DLCO is reduced out of proportion to lung volumes (42% predicted despite TLC 64% predicted) because the pathologic hallmark of IPF is destruction of the alveolar-capillary interface and obliteration of the pulmonary capillary bed by fibrosis. This disproportionate DLCO reduction is a cardinal feature of interstitial lung disease and correlates with severity of fibrosis and pulmonary vascular involvement. Per Harrison 21e Ch 287 and ATS/ERS IPF Guidelines 2022, DLCO <40% predicted suggests advanced disease and possible secondary pulmonary hypertension.

    Why each distractor is wrong

    • Airway obstruction reducing ventilation to distal alveoli: This describes obstructive physiology (pattern B), not restrictive. In pattern A, airway caliber is preserved; the problem is parenchymal stiffness and capillary destruction, not obstruction.
    • Increased total lung capacity due to air trapping in emphysematous spaces: This describes obstructive pattern (B) with TLC >120% predicted. Pattern A has TLC <80% predicted, reflecting restrictive mechanics, not air trapping.
    • Preserved airway caliber with normal gas diffusion capacity: While airway caliber is indeed preserved in pattern A, gas diffusion capacity is NOT normal—DLCO is markedly reduced (42% predicted), which is the key finding that distinguishes IPF from extrapulmonary causes of restriction.
    High-YieldNEET PG
    In restrictive ILD, DLCO is reduced out of proportion to TLC reduction because fibrosis destroys the alveolar-capillary membrane; DLCO <40% predicts advanced disease and mortality risk.

    Harrison 21e Ch 287; ATS/ERS IPF Guidelines 2022; Raghu Am J Respir Crit Care Med 2022

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Medicine Questions

    Join our NEET PG community

    Daily MCQs, study tips, and topper strategies on Telegram.

    Join on Telegram →